ArticleScientific reports2025
Cooperative role of MDSCs and Tregs in alum-induced alloimmune tolerance in corneal transplantation.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Alum, a widely used adjuvant, has recently been recognized for its capacity to modulate immune responses beyond classical activation. In this study, we investigated whether alum-induced expansion of myeloid-derived suppressor cells (MDSCs) and their interaction with regulatory T cells (Tregs) promote immune tolerance in corneal transplantation. C57BL/6 mice received repeated intraperitoneal alum injections to induce MDSCs, which were subsequently characterized and tested in suppression assays. Corneal allograft recipients were treated with alum, adoptive transfer of alum-induced MDSCs, or combined transfer of MDSCs and Tregs. Alum significantly expanded MDSCs in the spleen, blood, and bone marrow, and suppressed CD4⁺ T cell proliferation. Compared with MDSCs transfer alone, alum treatment more effectively prolonged allograft survival (50% vs. 20% tolerance), increased Foxp3⁺ Tregs and IL-10⁺ Treg cells, and reduced Th17 responses. Co-transfer of MDSCs and Tregs further enhanced graft survival (~ 60%), indicating a synergistic effect. These findings suggest that alum enhances transplant tolerance through both expansion and activation of MDSCs and Tregs, providing mechanistic insight into its immunosuppressive potential and offering a rationale for combined cell-based strategies in transplantation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.